RLEFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
TSAMX
Price
$14.85
Change
+$0.03 (+0.20%)
Updated
Oct 17 closing price
Net Assets
97.4M
Interact to see
Advertisement

RLEFX vs TSAMX

Header iconRLEFX vs TSAMX Comparison
Open Charts RLEFX vs TSAMXBanner chart's image
American Funds American Balanced R5E
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
Thornburg Summit A
Price$14.85
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets97.4M
RLEFX vs TSAMX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 265B vs. TSAMX (97.4M). RLEFX pays higher dividends than TSAMX: RLEFX (1.92) vs TSAMX (1.75). RLEFX was incepted earlier than TSAMX: RLEFX (10 years) vs TSAMX (4 years). TSAMX (1.81) is less costly to investors than RLEFX (0.39). TSAMX is a more actively managed with annual turnover of: 66.54 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than TSAMX: RLEFX (250) vs TSAMX (5000). TSAMX annual gain was more profitable for investors over the last year : 13.15 vs. RLEFX (8.94).
RLEFXTSAMXRLEFX / TSAMX
Total Expense Ratio0.390.9641%
Annual Report Gross Expense Ratio0.391.8122%
Fund Existence10 years4 years-
Gain YTD14.81917.23086%
Front LoadN/A5%-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets265B97.4M272,074%
Annual Yield % from dividends1.921.75110%
Returns for 1 year8.9413.1568%
Returns for 3 years51.3951.7399%
Returns for 5 years43.26N/A-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
STC69.760.91
+1.32%
Stewart Information Services Corp
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma
SRTA4.99-0.09
-1.77%
Strata Critical Medical Inc